| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $197,450,380 ) (Continued on the next page) |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES035760 | Impact of Phthalate Exposure on Telomere Biology in Utero | 000 | 3 | NIH | 1/29/2026 | $359,000 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH129934 | Iron deficits and their relationship with symptoms and cognition in Psychotic Spectrum Disorders | 000 | 4 | NIH | 2/11/2026 | $717,083 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA266345 | Multinuclear MRI to Monitor Breast Cancer Therapy | 001 | 4 | NIH | 4/20/2026 | $70,295 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA266345 | Multinuclear MRI to Monitor Breast Cancer Therapy | 000 | 4 | NIH | 12/16/2025 | $632,659 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH137629 | 3/5 Clinical Outcome Prediction of Psychosis from Electronic Health Records (COPPER) | 000 | 3 | NIH | 5/28/2026 | $211,875 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC012557 | Synaptic basis of perceptual learning with cochlear implants in rat auditory cortex - Renewal | 000 | 14 | NIH | 12/5/2025 | $604,873 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC012557 | Synaptic basis of perceptual learning with cochlear implants in rat auditory cortex - Renewal | 001 | 14 | NIH | 2/10/2026 | $67,207 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA266978 | Molecular basis for aberrant de novo DNA methylation in cancer | 001 | 5 | NIH | 4/16/2026 | $53,241 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA266978 | Molecular basis for aberrant de novo DNA methylation in cancer | 000 | 5 | NIH | 1/27/2026 | $479,168 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG092953 | Peripheral immunity and the aging brain: Studying the relationship of platelet and neutrophil activity with markers of vascular contributions to cognitive decline and dementia | 001 | 2 | NIH | 5/25/2026 | $1,547,425 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01AI174997 | Safety and efficacy of Belatacept in heart transplantation | 000 | 4 | NIH | 4/21/2026 | $2,042,672 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DA063711 | NY MOVES: Evaluating the Impact of New York’s Methadone Outreach VEhicleS | 001 | 2 | NIH | 5/25/2026 | $775,500 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HD120238 | Strengthening Screening and Referral Systems to Address Early Childhood Obesity Risk | 000 | 2 | NIH | 5/12/2026 | $722,724 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK143287 | Increasing kidney transplants with stratified kidney allocation: acceptability and impacts | 000 | 1 | NIH | 2/19/2026 | $847,495 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23NS146694 | Quantitative Gait Metrics to Assess and Predict Gross Motor Impairment in Young Children with Neurofibromatosis Type 1 | 000 | 1 | NIH | 1/23/2026 | $247,995 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG090618 | Technologies to probe the biophysical properties of aging cells | 000 | 1 | NIH | 1/23/2026 | $708,137 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | P01AI181994 | The Use of the Pig-to-Human Decedent Model to Optimize Future Results in Clinical Xenotransplantation Trials | 000 | 1 | NIH | 4/17/2026 | $2,064,597 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG091450 | A prospective study of viral infections and subsequent risk of Alzheimer’s disease | 000 | 1 | NIH | 1/23/2026 | $712,578 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01DA063565 | Neurobehavioral Mechanisms of Social Behavior and Familial Structure | 000 | 1 | NIH | 3/9/2026 | $1,240,576 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AG093093 | (Micro)structural Biomarkers of Skeletal Muscle Health Across the Lifespan | 000 | 1 | NIH | 1/9/2026 | $466,125 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DA064979 | A Social Network Approach to Improve HIV Prevention and Substance Use Treatment for People Who Use Drugs | 000 | 1 | NIH | 3/9/2026 | $771,043 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | DP2AI184743 | Move, Eat, Trap, or Kill: Decoding the molecular logic used by innate immune cells to decide between functional programs | 000 | 1 | NIH | 4/24/2026 | $508,500 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31MH143451 | Unraveling Cerebellar Contributions to Schizophrenia Spectrum Disorders: Integrating Function, Structure, and Iron Content | 000 | 1 | NIH | 4/6/2026 | $50,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32AI197563 | Blocking pathogenic anti-donor antibody responses | 000 | 1 | NIH | 3/30/2026 | $75,520 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32AI197563 | Blocking pathogenic anti-donor antibody responses | 001 | 1 | NIH | 4/13/2026 | $1,260 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R13NS149699 | Tools and Resources to Understand Pathophysiology with Post-Mortem Studies of in vivo Neuroimaging Findings in AD and ADRD | 000 | 1 | NIH | 5/7/2026 | $10,000 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R13NS149699 | Tools and Resources to Understand Pathophysiology with Post-Mortem Studies of in vivo Neuroimaging Findings in AD and ADRD | 000 | 1 | NIH | 5/7/2026 | $10,000 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH142698 | Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia | 000 | 1 | NIH | 2/19/2026 | $871,225 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG092496 | Midlife circulating autoantibodies and the risk of Alzheimer’s disease in Women | 000 | 1 | NIH | 1/27/2026 | $724,813 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R34DA064469 | PrEP-RISE: A Multi-Level PhotoVoice Intervention to Improve PrEP Uptake and Adherence Among Women Who Inject Drugs (WWID) | 000 | 1 | NIH | 5/19/2026 | $256,165 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R37CA248631 | Deconstructing and targeting aneuploidy in human cancer | 000 | 6 | NIH | 5/7/2026 | $477,848 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI198070 | HOPE Heart study: A Clinical Trial of HIV to HIV Transplantation | 000 | 1 | NIH | 4/21/2026 | $1,717,417 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES037346 | Evaluating Health Impacts of NYC Congestion Pricing | 000 | 1 | NIH | 4/27/2026 | $4,128,432 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30DC023803 | Bayesian time warping for data-efficient communication brain-computer interfaces | 001 | 1 | NIH | 4/28/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30DC023803 | Bayesian time warping for data-efficient communication brain-computer interfaces | 000 | 1 | NIH | 4/28/2026 | $55,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG080769 | Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal Study | 001 | 2 | NIH | 4/17/2026 | $377,253 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG080769 | Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal Study | 000 | 2 | NIH | 3/20/2026 | $239,898 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23NS146693 | Mechanisms and Prognostic Value of Ictal Onset Patterns for Epilepsy Neurostimulation | 000 | 1 | NIH | 2/20/2026 | $247,994 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI189754 | Regulation of CD4+ and CD8+ T cell function by CLNS1A | 000 | 1 | NIH | 2/3/2026 | $755,801 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH140431 | Prenatal maternal brain plasticity and associations with maternal and infant neurobehavioral health | 000 | 1 | NIH | 3/5/2026 | $771,272 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UM1TR005769 | New York University Clinical and Translational Science Hub | 000 | 1 | NIH | 4/1/2026 | $9,581,287 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UM1TR005769 | New York University Clinical and Translational Science Hub | 001 | 1 | NIH | 5/27/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI191646 | Perivascular macrophages control the severity of experimental autoimmune encephalomyelitis | 000 | 1 | NIH | 2/3/2026 | $466,125 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI190164 | Intestinal Programming of Gut-Associated Germinal Centers | 000 | 1 | NIH | 2/4/2026 | $791,797 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG077103 | Septhohippocamal connectome dysfunction in Down syndrome associated with Alzheimer’s disease pathophysiology | 001 | 2 | NIH | 3/16/2026 | $80,543 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG077103 | Septhohippocamal connectome dysfunction in Down syndrome associated with Alzheimer’s disease pathophysiology | 000 | 2 | NIH | 2/5/2026 | $724,879 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG094086 | GABAergic Circuit Targets for Modulating Entorhinal Cortex and Hippocampal Dynamics in Alzheimer's Disease | 000 | 1 | NIH | 1/14/2026 | $642,063 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI198140 | Antibody signatures of HIV treatment effectiveness: toward low-cost rapid tests for treatment monitoring | 000 | 1 | NIH | 3/27/2026 | $841,719 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS142136 | Mechanistic Insights Underlying LZTR1-Related Schwannomatosis | 000 | 1 | NIH | 1/7/2026 | $579,610 |
|
